19 May 2013
Keywords: genentech, invests, uk, company, biotechnology, invested, million
Article | 14 August 1995
US biotechnology company Genentech has invested $2 million and drawn up a licensing agreement with Cambridge Antibody Technology, an antibody technology ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.